SMF Notes More Upside for HGSI Celgene mulls Human Genome Sciences Exclusive

http://www.StockMarketFunding.com More Upside for HGSI Celgene mulls Human Genome Sciences Exclusive. Human Genome Sciences Inc (HGSI) shares climbed 5.36 pe...


Exclusive: Celgene mulls Human Genome Sciences bid - source

Celgene Corp is one of two companies discussing whether to bid for Human Genome Sciences Inc , which seeks an alternative to a hostile offer by British drug maker GlaxoSmithKline Plc , a source familiar with the situation said.

Conventional wisdom among investors has been that Human Genome was unlikely to find another bidder, as Glaxo reaps 50 percent of the profit from the lupus drug Benlysta, to which Glaxo and Human Genome share the rights.